TRI NURCAHYADI NISWANTORO
041424353030
Supervisor
Dr. Gancar Candra Premananto, SE., MSi.
ABSTRACT
The pharmaceutical industry in Indonesia has become one of the most important strategic industries in the country.
In early 2014, Indonesia held health insurance for all its people, namely the National Health Insurance of its people, National Health Insurance (JKN). The foreign pharmaceutical industry is impacted very much because they are not able to meet the price of drugs that have been set in the E-Catalog according to the standards set by the government, By looking at PT. sales table, it can be seen that the sales growth of PT. XYZ compared to similar companies cannot compete. PT.XYZ is one of the companies involved in health, namely pharmacy.
To date, PT. With the increasingly tight competition in the industry and the enactment of the National Health Insurance (JKN) program by the government then the company will gradually be adversely affected. Therefore, this study aims to provide an effective business strategy so that the company can maintain the company's business continuity in facing the business environment and can increase the competitive advantage. This research uses Internal External Factor Evaluation (IFE & EFE) Matrix method, Internal External (IE) Matrix, TOWS Matrix. The results of this study indicate that PT. The alternative strategies derived from the TOWS plotting matrix are: (1) Focus on high potential areas that can create demand (sales); (2) Cooperate with parties in each region; and (3) Adding new product variants (launch of cutivate, Relvar, and Anoro).
Keywords: Pharmaceutical industry, Business strategy formulation, Internal Factor Evaluation (IFE) Matrix, External Factor Evaluation (EFE) Matrix, Internal External (IE) Matrix, TOWS Matrix.
